Informations sur le produit
LOXO-195 is a potent and selective inhibitor of human cyp3a4, an important enzyme in the body for metabolizing many drugs. LOXO-195 has been shown to be effective in vitro against wild-type cancer cells and resistant mutants. It also has a low toxicity profile, with no observed effects on primary analysis, pharmacokinetic properties, or tumor growth in vivo. The molecular modeling of this molecule supports its potential as a drug candidate for the treatment of cancer.